Zobrazeno 1 - 10
of 431
pro vyhledávání: '"Matthias Loebe"'
Autor:
Jose R. Navas-Blanco, Sofia A. Lifgren, Roman Dudaryk, Jeffrey Scott, Matthias Loebe, Ali Ghodsizad
Publikováno v:
BMC Anesthesiology, Vol 21, Iss 1, Pp 1-5 (2021)
Abstract Background The complexity of extracorporeal membrane oxygenation (ECMO) techniques continues to evolve. Different cannulation methods and configurations have been proposed as a response to a challenging cardiovascular and pulmonary physiolog
Externí odkaz:
https://doaj.org/article/8148907b9e864cb2b2be8060dba409c5
Autor:
Kristin M. Kostick, Meredith Trejo, Arvind Bhimaraj, Andrew Civitello, Jonathan Grinstein, Douglas Horstmanshof, Ulrich P. Jorde, Matthias Loebe, Mandeep R. Mehra, Nasir Z. Sulemanjee, Vinay Thohan, Barry H. Trachtenberg, Nir Uriel, Robert J. Volk, Jerry D. Estep, J. S. Blumenthal-Barby
Publikováno v:
BMC Medical Informatics and Decision Making, Vol 21, Iss 1, Pp 1-14 (2021)
Abstract Background A central goal among researchers and policy makers seeking to implement clinical interventions is to identify key facilitators and barriers that contribute to implementation success. Despite calls from a number of scholars, empiri
Externí odkaz:
https://doaj.org/article/9695199d1d6a42ae9161fd1129c7f276
Autor:
Brian A. Bruckner MD, William D. Spotnitz MD, Erik Suarez MD, Matthias Loebe MD, PhD, Uy Ngo PA, Daniel L. Gillen PhD, Roberto J. Manson MD
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 27 (2021)
This clinical study compares 2 hemostatic agents, a novel combination powder (CP) (HEMOBLAST ™ Bellows) and an established polysaccharide starch powder (PP) (Arista ™ AH) to assess the usefulness of CP. Retrospective comparative analysis of CP (J
Externí odkaz:
https://doaj.org/article/5eb3020177dd4241a0473a1c8d876a94
Autor:
Camila Iansen Irion, Julian C. Dunkley, Krista John-Williams, José Manuel Condor Capcha, Serene A. Shehadeh, Andre Pinto, Matthias Loebe, Keith A. Webster, Nicolas A. Brozzi, Lina A. Shehadeh
Publikováno v:
Frontiers in Physiology, Vol 11 (2020)
BackgroundHeart transplant is the gold standard therapy for patients with advanced heart failure. Over 5,500 heart transplants are performed every year worldwide. Cardiac allograft vasculopathy (CAV) is a common complication post-heart transplant whi
Externí odkaz:
https://doaj.org/article/0316fc2c19f145d097b3e555a08a813d
Autor:
Dewei Ren, MD, Thomas S. Kaleekal, MD, Edward A. Graviss, PhD, MPH, Duc T. Nguyen, MD, PhD, Neeraj Sinha, MD, Amad Goodarzi, MD, Isioma Agboli, MD, Erik E. Suarez, MD, Matthias Loebe, MD, PhD, Scott A. Scheinin, MD, Brian A. Bruckner, MD, PhD
Publikováno v:
Transplantation Direct, Vol 4, Iss 11, p e404 (2018)
Background. With the increase of primary lung transplantation across major centers worldwide, over the last several years the need of lung retransplant (ReTX) is likely to increase. Therefore, characterization of ReTX patients is prudent and necessar
Externí odkaz:
https://doaj.org/article/eccf1e2bbf964c1ab4b698443057e99a
Publikováno v:
Mastering Structural Heart Disease. :567-570
Publikováno v:
Mastering Structural Heart Disease. :227-232
Publikováno v:
Mastering Structural Heart Disease. :343-346
Publikováno v:
Clinical Transplantation.
Publikováno v:
JTCVS Techniques. 13:115-118